These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19538)

  • 1. Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae.
    Young LS; Stevens P
    J Infect Dis; 1977 Aug; 136 Suppl():S174-80. PubMed ID: 19538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role of antibody against "core" glycolipid of Enterobacteriaceae.
    Young LS; Stevens P; Ingram J
    J Clin Invest; 1975 Oct; 56(4):850-61. PubMed ID: 1099119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.
    McCabe WR; Bruins SC; Craven DE; Johns M
    J Infect Dis; 1977 Aug; 136 Suppl():S161-6. PubMed ID: 330775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections.
    Ng AK; Chen CL; Chang CM; Nowotny A
    J Gen Microbiol; 1976 May; 94(1):107-16. PubMed ID: 778329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escherichia coli antibodies in opsonisation and protection against infection.
    van Dijk WC; Verbrugh HA; van Erne-van der Tol ME; Peters R; Verhoef J
    J Med Microbiol; 1981 Nov; 14(4):381-9. PubMed ID: 7031250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precipitating antibody against core glycolipid of Enterobacteriaceae.
    Young LS; Stevens PR
    Experientia; 1974 Feb; 30(2):192-3. PubMed ID: 4205369
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific and Nonspecific immunity to Serratia marcescens infection.
    Simberkoff MS; Moldover NH; Rahal JJ
    J Infect Dis; 1976 Oct; 134(4):348-53. PubMed ID: 789788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of shared antigens for immunization against gram-negative bacillary infections.
    McCabe WR; DeMaria A; Johns M
    Prog Clin Biol Res; 1980; 47():107-17. PubMed ID: 6163155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.
    Bogard WC; Dunn DL; Abernethy K; Kilgarriff C; Kung PC
    Infect Immun; 1987 Apr; 55(4):899-908. PubMed ID: 3549565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant.
    Bruins SC; Stumacher R; Johns MA; McCabe WR
    Infect Immun; 1977 Jul; 17(1):16-20. PubMed ID: 407161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocytosis as a surface phenomenon. II. Contact angles and phagocytosis of encapsulated bacteria before and after opsonization by specific antiserum and complement.
    Van Oss CJ; Gillman CF
    J Reticuloendothel Soc; 1972 Nov; 12(5):497-502. PubMed ID: 4120360
    [No Abstract]   [Full Text] [Related]  

  • 12. Opsonization of serum-sensitive and serum-resistant Escherichia coli by rough mutant (Re) antisera.
    Crowley JP; Zinner SH; Peter G
    J Lab Clin Med; 1982 Feb; 99(2):197-205. PubMed ID: 7038008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental gram-negative bacterial sepsis: reevaluation of the ability of rough mutant antisera to protect mice.
    Greisman SE; DuBuy JB; Woodward CL
    Proc Soc Exp Biol Med; 1978 Jul; 158(3):482-90. PubMed ID: 356058
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutant.
    McCabe WR; DeMaria A; Berberich H; Johns MA
    J Infect Dis; 1988 Aug; 158(2):291-300. PubMed ID: 3042871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality.
    Greisman SE; Johnston CA
    J Infect Dis; 1988 Jan; 157(1):54-64. PubMed ID: 2447200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of active and passive immunizations with lipid A and salmonella minnesota Re 595 on gram-negative infections in mice.
    Hodgin LA; Drews J
    Infection; 1976; 4(2):5-10. PubMed ID: 789248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of bacterial diseases by detection of serum antigens by counterimmunoelectrophoresis, sensitivity, and specificity of detecting Pseudomonas and pneumococcal antigens.
    Bartram CE; Crowder JG; Beeler B; White A
    J Lab Clin Med; 1974 Apr; 83(4):591-8. PubMed ID: 4150397
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
    Hussein KE; Bahey-El-Din M; Sheweita SA
    Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse protection induced by Pseudomonas aeruginosa PAC1R and its defective mutants, Salmonella minnesota Re-mutant and Escherichia coli O14.
    Stanislavsky ES; Kholodkova EV; Makarenko TA; Sukhachevskaya MV
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):81-6. PubMed ID: 7640675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
    McCabe WR
    J Immunol; 1972 Mar; 108(3):601-10. PubMed ID: 4622185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.